Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIA Study of Descartes-30 in Acute Respiratory Distress Syndrome

NCT04524962 is registered in ClinicalTrials.gov with Cartesian Therapeutics as lead sponsor.

NCT NCT04524962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIA Study of Descartes-30 in Acute Respiratory Distress Syndrome
Lead sponsor
Cartesian Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
February 23, 2021
Completion date
September 9, 2023
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid19